» Authors » Matthias H Munk

Matthias H Munk

Explore the profile of Matthias H Munk including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 42
Citations 277
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Haag L, Lancini E, Yakupov R, Ziegler G, Yi Y, Lusebrink F, et al.
Brain Commun . 2025 Feb; 7(1):fcaf031. PMID: 39926613
Neurotransmitter systems of noradrenaline, dopamine, serotonin and acetylcholine are implicated in cognitive functions such as memory, learning and attention and are known to be altered in neurodegenerative diseases like Alzheimer's...
2.
Schneider L, Freiesleben S, van Breukelen G, Wang X, Brosseron F, Heneka M, et al.
Alzheimers Dement . 2025 Jan; 21(2):e14545. PMID: 39868793
Introduction: The beneficial effects of amyloid beta 1-38, or Aβ(1-38), on Alzheimer's disease (AD) progression in humans in vivo remain controversial. We investigated AD patients' cerebrospinal fluid (CSF) Aβ(1-38) and...
3.
Blomeke L, Rehn F, Pils M, Kraemer-Schulien V, Cousin A, Kutzsche J, et al.
Commun Med (Lond) . 2024 Dec; 4(1):262. PMID: 39658587
Background: Quantification of Amyloid beta (Aβ) oligomers in plasma enables early diagnosis of Alzheimer's Disease (AD) and improves our understanding of underlying pathologies. However, quantification necessitates an extremely sensitive and...
4.
Vockert N, Machts J, Kleineidam L, Nemali A, Incesoy E, Bernal J, et al.
Nat Commun . 2024 Nov; 15(1):9815. PMID: 39537609
The cognitive reserve (CR) hypothesis posits that individuals can differ in how their brain function is disrupted by pathology associated with aging and neurodegeneration. Here, we test this hypothesis in...
5.
Martinelli F, Heinken A, Henning A, Ulmer M, Hensen T, Gonzalez A, et al.
Sci Rep . 2024 Nov; 14(1):27692. PMID: 39532987
No abstract available.
6.
Menze I, Bernal J, Kaya P, Aki C, Pfister M, Geisendorfer J, et al.
Alzheimers Res Ther . 2024 Nov; 16(1):242. PMID: 39482759
Background: Perivascular space (PVS) enlargement in ageing and Alzheimer's disease (AD) and the drivers of such a structural change in humans require longitudinal investigation. Elucidating the effects of demographic factors,...
7.
Konig A, Kohler S, Troger J, Duzel E, Glanz W, Butryn M, et al.
Alzheimers Dement (Amst) . 2024 Oct; 16(4):e70011. PMID: 39376498
Introduction: We investigated the agreement between automated and gold-standard manual transcriptions of telephone chatbot-based semantic verbal fluency testing. Methods: We examined 78 cases from the Screening over Speech in Unselected...
8.
Shao K, Hu X, Kleineidam L, Stark M, Altenstein S, Amthauer H, et al.
Alzheimers Dement . 2024 Jul; 20(9):5926-5939. PMID: 39072956
Introduction: Subjective cognitive decline (SCD) in amyloid-positive (Aβ+) individuals was proposed as a clinical indicator of Stage 2 in the Alzheimer's disease (AD) continuum, but this requires further validation across...
9.
Soch J, Richter A, Kizilirmak J, Schutze H, Ziegler G, Altenstein S, et al.
Brain . 2024 May; 147(11):3789-3803. PMID: 38743817
Single-value scores reflecting the deviation from (FADE score) or similarity with (SAME score) prototypical novelty-related and memory-related functional MRI activation patterns in young adults have been proposed as imaging biomarkers...
10.
Dorner M, Seebach K, Heneka M, Menze I, von Kanel R, Euler S, et al.
Diagnostics (Basel) . 2024 May; 14(9). PMID: 38732354
Inferior frontal sulcal hyperintensities (IFSHs) on fluid-attenuated inversion recovery (FLAIR) sequences have been proposed to be indicative of glymphatic dysfunction. Replication studies in large and diverse samples are nonetheless needed...